R J Pomerantz
- Co-authors
- David BaltimoreMark B. FeinbergDidier TronoGeethanjali DornadulaLiping DuanH ZhangJoseph KulkoskyMohamad Bouhamdan
- Topics
- HIV Research and Treatment (12 papers)HIV/AIDS drug development and treatment (5 papers)Immune Cell Function and Interaction (5 papers)
- Partner nations
- United States
In The Last Decade
R J Pomerantz
15 papers receiving 608 citations
Peers
Comparison fields: 5 of 66
- Virology 411
- Infectious Diseases 245
- Molecular Biology 217
- Immunology 186
- Epidemiology 115
Countries citing papers authored by R J Pomerantz
This map shows the geographic impact of R J Pomerantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R J Pomerantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R J Pomerantz more than expected).
Fields of papers citing papers by R J Pomerantz
This network shows the impact of papers produced by R J Pomerantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R J Pomerantz. The network helps show where R J Pomerantz may publish in the future.
Co-authorship network of co-authors of R J Pomerantz
This figure shows the co-authorship network connecting the top 25 collaborators of R J Pomerantz. A scholar is included among the top collaborators of R J Pomerantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R J Pomerantz. R J Pomerantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 25 | |
| 2 | 78 | |
| 3 | 16 | |
| 4 | Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core. | 37 |
| 5 | Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies. | 17 |
| 6 | 44 | |
| 7 | Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women. | 32 |
| 8 | 12 | |
| 9 | Natural endogenous reverse transcription of HIV type 1. | 12 |
| 10 | 2 | |
| 11 | 95 | |
| 12 | A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat. | 22 |
| 13 | 9 | |
| 14 | 31 | |
| 15 | 187 |
About R J Pomerantz
R J Pomerantz is a scholar working on Virology, Immunology and Infectious Diseases, having authored 15 papers that have together received 619 indexed citations. Recurring topics across this work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (5 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Virology (411 citations), Infectious Diseases (245 citations) and Immunology (186 citations). R J Pomerantz has collaborated with scholars based in United States. Frequent co-authors include David Baltimore, Mark B. Feinberg, Didier Trono, Geethanjali Dornadula, Liping Duan, H Zhang, Joseph Kulkosky, Mohamad Bouhamdan, Zhu Ming and A M Skalka. Their work appears in journals such as The Journal of Experimental Medicine, Clinical Infectious Diseases and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.